Doyle Anthony bought BCRX
May 14, 2024 · Form 4 insider transaction
Doyle Anthony bought 36,300 shares of BioCryst Pharmaceuticals, Inc. at $5.57 per share, a transaction worth $202.2K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
36,300
Price
$5.57
Total value
$202.2K
InsiderDoyle Anthony
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 14, 2024
Filing dateMay 15, 2024
Shares owned after266,744
OwnershipDirect
10b5-1 planNo
AmendedNo